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Purpose: Intimal hyperplasia (IH) poses the greatest challenge for vein graft success. This 
fibroproliferative disorder causes obliterative stenosis and frequent graft occlusion. 
Although its causes remain poorly understood, it has been proposed that IH begins as a 
wound-healing response that cascades into a chronic state of unchecked proliferation. In 
this ultrastructural study, IH development and concomitant cell changes were evaluated 
in rat vein grafts. 
Methods: Epigastric vein-to-femoral rtery grafts were placed in Lewis rats using standard 
microsurgical techniques. At various time points, grafts were harvested and processed for 
transmission electron microscopic, histologic, and immunohistochemical analyses. The 
proximal region, which displayed the most marked IH, was assessed for ultrastrucmral 
changes. 
Results: Our findings showed: (1) regeneration of the damaged endothelium by cells 
displaying an activatedappearance; (2) early and complete smooth muscle cell death, with 
subsequent replacement by myofibroblastic cells; (3) extensive and sustained graft infil- 
tration by monocytes/macrophages; and (4) intramural fibrin deposition. 
Conclusions: The rat vein graft wall was substantially altered after implantation i to the 
arterial circulation. During and after IH development, the cells in the graft did not 
resemble cells that are present in the nongrafted epigastric vein. Marked cell death, 
mononuclear cell infiltration, and the presence of myofibroblastic cells suggest a state of 
aberrant wound healing. (J Vasc Surg 1997;26:94-103.) 
Autogenous vein grafts are commonly used for 
arterial reconstructive procedures. Their success is 
limited by the development of intimal hyperplasia 
(IH), which predisposes the grafts to occlusive steno- 
sis. IH is a fibroproliferative thickening of the vein 
intima that is characterized by initially eccentric le- 
sions that consist mainly of mesenchymal cells and 
extracelhilar matrix. 1 The cause of this neoinfimal 
development in vein grafts is poorly understood, and 
clinical interventions have not been successful. Nu- 
merous causes have been proposed, including surgi- 
cal trauma, ischemia of the vein wall, 2 and altered 
hemodynamics3; however, the mechanisms that gov- 
ern cell behavior in the vein wall have not been 
defined. 
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Much of the knowledge of IH in vein grafts is 
based on information learned from the study of IH in 
arterial animal models, such as those ofatherosclero- 
sis, balloon injury, and allograft rejection. Although 
the histologic appearance of vein graft IH resembles 
that of arterial IH, it is likely that this process differs 
in injured veins, whose composition and responses to 
insult differ from those of arteries. Grafted veins are 
subjected to unique local and chronic traumas, which 
include inappropriate graft preparation, prolonged 
ischemia, unfamiliar tangential and shear stresses, 
compliance mismatch, and elevated blood pressure. 
IH lesions een in human vein grafts are mimicked by 
those in animal vein graft models. 4 8 In our previous 
studies of IH in rat vein grafts, we assessed the 
histologic and morphometric changes in the vascular 
wall. 8 The present study was undertaken to examine, 
at an ultrastructural level, the temporal and spatial 
changes in the composition and organization of the 
vein graft wall at the region of the most marked 
neointimal proliferation. 
MATERIALS AND METHODS 
Microsurgical vein grafting. Fifty-six epigastric 
vein-to-femoral artery grafts were implanted into 
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Table I. Antibodies and conditions for immunohistochemical analysis 
Cell type Antigen Location Clone Isotype Dilution Source 
SMC, MF c~-actin cytoplasm asm-1 mouse IgGza 1:100 Boehringer 
Mannheim 
Monocyte/macrophage 97kD cytoplasm + membrane EDI mouse IgG 1 1:100 Serotec 
- -  Fibrinogen/fibrin intra/extracellular polyclonal rabbit IgG neat Incstar 
MF, Myofibroblast. 
male Lewis rats (350 to 450 g) using standard micro- 
surgical techniques as previously described, s Briefly, 
each rat was anesthetized byintraperitoneal injection 
of ketamine/xylazine. Both the right epigastric vein 
and right femoral artery were iSolated under 10× 
magnification with minimum adventitial dissection. 
An 8 mm length of relaxed vein was excised, gently 
irrigated with heparinized (5 U/ml) saline solution 
(pH 7.2), reversed, and interposed into a 3 mm 
arterial defect. The proximal and distal ends of both 
vessels were slightly distended, trimmed, and aligned 
in the normal direction of flow. At each anastomosis 
eight interrupted sutures were placed using 10-0 
nylon. Total ischemic time was 45 minutes. After 
reperfusion and visual confirmation of graft patency, 
the wound was closed using 3-0 silk suture and the 
animal was allowed to recover. Harvest ime points 
were: 1 and 4 hours; 1, 4, 7, and 10 days; and 2, 3, 4, 
6, 8, 10, and 12 weeks. All grafts were compared 
with nongrafted epigastric veins, as sham operations 
such as vein-to-vein grafting or vein clamping expe- 
rience unacceptably high rates of thrombosis as a 
result of low venous flow velocities and operative 
trauma. Animals were ldlled after harvest by CO 2 
inhalation. Animal care complied with the "Princi- 
ples of Laboratory Animal Care" (formulated by the 
National Society for Medical Research) and the 
Guide for the Care and Use of Laboratory Animals 
(NIH Publication No. 86-23, revised 1985). 
Transmission electron microscopy. Two ani- 
mals per time point and two nongrafted epigastric 
veins were examined. At the time of harvest, each 
animal was anesthetized byintraperitoneal injection 
with ketamine/xylazine and the patent vein graft was 
exposed. In situ immersion fixation was performed: a 
2 mm segment distal to the proximal anastomosis (1 
mm distal to the anastomosis) was excised, fixed in 
2.5% glutaraldehyde buffered in 0.1 mol/L sodium 
cacodylate (pH 7.2), and postfixed in 1% osmium 
tetroxide. After dehydration i graded alcohol solu- 
tions, the specimens were embedded in Epon- 
Araldite. Thick (1 ixm) sections were cut and stained 
with toluidine blue. Thin (90 nm) sections were cut, 
placed on copper grids, and stained with uranyl ace- 
tate and lead citrate. Three separate sections from 
each segment were examined using a Hitachi H500 
transmission electron microscope (TEM) at various 
magnifications. Each vein was examined around the 
entire circumference and through all wall layers by 
one of the authors (T.W.), and representative photo- 
graphs were taken. 
Immunohistochemical andhistologic analysis. 
Confirmatory immunostaining was performed for 
verification of TEM findings. A separate set of grafts 
(two grafts per time point) was analyzed in a blinded 
fashion. Antibodies and previously optimized condi- 
tions are listed in Table I. 
Grafts were harvested as previously described s,37 
with modifications. Briefly, each graft was infused 
with 7% gelatin, placed in embedding compound, 
and snap-frozen over liquid nitrogen. Serial trans- 
verse cryostat sections (5 b~m; cut at 500 Ixm inter- 
vals) were stained for e~-actin, monocytes/macro- 
phages, and fibrinogen/fibrin. Endogenous peroxidase 
was quenched with 0.3% H202,  and nonspecific 
binding was blocked with 2% bovine serum albumin 
(BSA). Specimens were incubated with primary anti- 
bodies (5 Ixg/ml) at 4 ° C overnight, followed by a 
biotinylated or fluorescein isothiocyanate-labeled 
secondary antibody at room temperature for 30 min- 
utes. Incubation with streptavidin-peroxidase (room 
temperature, 30minutes) was followed by the addi- 
tion of substrate 3'3'diaminobenzidine. Specimens 
were countcrstained lightly with methyl green. All 
washes were in phosphate-buffered saline solution 
(pH 7.5). Parallel staining with isotype-matched 
antibodies ensured specificity of the test antibod- 
ies. For confirmation of graft architecture and 
components, ections were stained with Verhoeff- 
van Gieson elastin stain. Morphometric analysis of 
neointimal areas was performed using computer- 
ized planimetry as previously described, s 
RESULTS 
Microsurgery. The animal survival and graft pa- 
tency rates were 100%. The subjects appeared 
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Fig. 1. IH is induced in rat vein grafts. A, Photomicrograph of 2-week graft transverse section 
shows developing neointima (N) above IEL (arrowhead). Proximal region, gelatin-filled lumen 
(L), Verhoeff-van Gieson staining, x80. B, Photomicrograph of 8-week graft transverse section 
demonstrates thickened neointima nd attenuated adventitia/media (A). Proximal region, 
gelatin-filled lumen (L), Verhoeff-van Gieson staining, ×80. C, Column chart represents 
increase in neointimal area over time. Error bars denote SEM; p < 0.02 for all time points as 
compared with nongrafted control vein. 
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healthy. There were no structural anomalies at the 
anastomotic regions of the grafts. The gross appear- 
ance of the veins and adjoining arteries was normal. 
Histologic analysis. IH developed in all grafts 
examined (Fig. l). Results agreed with our previ- 
ously published work. s Briefly, patches of luminal 
thrombus and focal inflammatory infiltrates were 
seen by 1 day, and by 2 weeks there was a quantifi- 
able eccentric neointima bove the internal elastic 
lamina (IEL) characterized by increased cellularity 
and extraccllular matrix. The media appeared atten- 
uated. The neointimal area increased until 6 weeks. 
The IEL was discernible at all rime points. 
Transmission electron microscopic examina- 
tion. The intima of the rat epigastric vein consisted 
of a flat continuous sheet of endothelial cells (EC) 
resting on a basal lamina. The IEL, separating the 
intima and the media, appeared as a discontinuous 
line of amorphous elastin underlying the endothe- 
lium. Smooth muscle cells (SMCs), surrounded by 
fascicles of mature collagen, were seen primarily in 
the media. They were invested with basal amina and 
appeared elongated, with typical myofilaments, 
dense bodies, and no rough endoplasmic reticulum. 
Processes of medial SMCs were seen occasionally 
penetrating the IEL to contact the endothelium. The 
adventitia was dominated by mature collagen fasci- 
cles. Occasional stellate fibroblasts with attenuated 
processes, probably sheetlike in their dimensions, 
were seen. 
By 1 to 4 hours after the grafting procedure there 
was evidence of endothelial damage. The EC mono- 
layer appeared attenuated, with occasional cell loss. 
Platelets adhered closely to the basal lamina. Poly- 
morphonuclcar leukocytes were detected at the lumi- 
nal surface and beneath the attenuated endothelium; 
pseudopods from polymorphonuclear leukocytes 
projected between platelets, through the basal am- 
ina, and between islands of elastics. The subendothe- 
lial space appeared edematous, and the IEL was cir- 
cumferentially elongated. Medial SMCs showed 
early degeneration (Fig. 2): circumferential elonga- 
tion, loss of surface corrugation and pinocytotic ves- 
icles, clustered mitochondria, pyknotic nuclei, and 
zonal or diffuse disorganization of contractile fila- 
ments. Some cells also contained ilated endoplas- 
mic reticulum. The basal amina remained intact. In 
the adventitia, some fibroblasts displayed a disrupted 
plasma membrane and vacuolated cytoplasm. There 
was focal infiltration by polymorphonuclear leuko- 
cytes. 
At 1 day flattened platelets adhered to the IEL, 
and fibrin was seen associated with extravasating leu- 
Fig. 2. Stretched and degenerating SMCs (M) in media 
of 4-hour graft, with polymorphonuclear leukocytes (ar- 
rowheads) in subendothelial space overlying IEL (E); intact 
smooth muscle at arrow. L, Lumen; F, fibroblast; EM 
x7000. 
kocytes. Medial SMC degeneration was extensive. 
The basal amina of SMCs remained; ma W of these 
"pseudomyotubes" were invaded by phagocytic 
polymorphonuclear leukocytes (Fig. 3). Dense defted 
deposits in some pseudomyotubes r embled fibrin. 
Mononuclear cells were present. Fascicles of collagen 
had become disorganized, and individual fibers were 
separated. In the advcntitia, elongated fibroblasts 
with pseudopods, myofibroblasts, and mononuclear 
cells were present. Mature collagen fascicles persisted 
between these cells. 
By 4 to 10 days the endothelium onolayer was 
largely restored; ECs appeared plump with attenu- 
ated peripheral cytoplasm, conspicuous rough endo- 
plasmic reticulum and gap junctions. This activated 
appearance of the ECs continued to be seen at all 
later time points. The basal amina was mostly absent 
and occasionally duplicated. The adherent platelets 
and polymorphonuclear leukocytes remained, and 
there was luminal deposition of fibrin and mononu- 
clear cells (Fig. 4). Mononuclear cells were also seen 
arrayed in a finear fashion above the IEL, although 
many showed egeneration in this region. Some du- 
plication of the elastica was detected. In the media, 
cell damage and necrosis was increased. No intact 
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Fig. 3. Polymorphonuclear leukocyte in empty pseudomyotube (arrow) in 1-day graft. De- 
generating SMCs (M) are visible in lower half of field. Row ofplatelets (arrowheads) adheres to 
IEL (E). L, Luixaen; C, collagen; EM ×7300. 
Fig. 4. Degenerating mononuclear cells (arrows) in fibrin 
deposit 09 beneath endothelium and above IEL (arrow- 
heads) in 1-week graft. Attenuated layer of degenerating 
SMCs (M) is seen beneath IEL. L, Lumen; EM ×3500. 
SMCs were seen, and fibrinlike material that dis- 
played a periodic pattern (16 nm) was present in 
some empty pseudomyotubes. A well-defined zone 
of necrosis external to the IEL persisted throughout 
all later time points. In the adventitia, proliferating 
fibroblasts and myofibroblasts increased in number, 
and immature collagen fibers were seen. 
At 2 to 3 weeks substantial mononuclear leuko- 
cyte accumulation and dense fibrin deposition were 
seen in the neointima (Fig. 5). A proteinaceous exu- 
date of unknown composition and cell debris were 
bounded by activated EC. Attenuated myofibroblas- 
tic processes were present between the IEL and pale, 
ill-defined collagen fibers. No typical SMCs were 
seen in the neointima; rather, mononuclear leuko- 
cytes were the dominant cell type. In the media and 
adventitia, the density of fibroblasts and myofibro- 
blasts had increased ramatically and remained con- 
sistent throughout all later time points. Capillaries 
were seen in the external adventitia. 
At 4 to 6 weeks many myofibroblasts were now 
present in the neointima; they contained rough en- 
doplasmic reticulum and were attenuated and less 
electron-dense than typical SMCs (Fig. 6). Some 
cells were invested by basal amina, but no pinocyto- 
sis was found. There were occasional foci of necrosis, 
with cell debris, fibrin, polymorphonuclear leuko- 
cytes, and mononuclear cells in nodules beneath the 
endothelium. 
At 8 to 12 weeks numerous myofibroblasts with 
abundant rough endoplasmic reticulum and occa- 
sional microfilaments predominated in the neoin- 
tima, although a few more differentiated SMCs were 
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now seen (Fig. 7). ECs continued to display an 
activated appearance, withextensive rough endoplas- 
mic reticulum. Focal cell debris, additional islands of 
elastin, and collagen were detected. The neointlmal 
mononuclear cells and fibrin were no longer seen. At 
the medial/neointimal interface the zone of necrosis 
persisted, although fewer leukocytes were detected. 
In the adventitia, the myofibroblasts and fibroblasts 
were more circumferentially elongated; long com- 
plex serpiginous extensions of these cells lay between 
collagen fascicles. Occasional eukocytes were de- 
tected. 
Immunostaining. Control vein a-actin-positive 
cells were restricted to the media. We found a de- 
crease in c~-actin staining in the media after the graft- 
ing procedure that correlated with SMC death: After 
an initial decrease in immunoreactivity, staining was 
detected in the media and adventitia by 4 days, and 
also in the neointima by 2 weeks. At all later time 
points, there was a trend toward decreased c¢-actin 
staining in the neointima (data not shown). Results 
of sections tained with isotype control mouse im- 
munoglobulin G2a (IgG2A) were negative. Immuno- 
staining for monocytes/macrophages confirmed 
TEM findings and previous workS: (1) monocytes/ 
macrophages, which were not present in nongrafted 
veins, were seen at the luminal surface by 1 day; (2) 
they infiltrated the entire vessel wall by 1 week; (3) 
they comprised a large part of the developing neoin- 
tima at 2 to 6 weeks (Fig. 8, A); and (4) they 
continued to reside in a region surrounding the IEL 
at all subsequent time points. Sections tained with 
isotype control mouse IgG 1 were negative. To con- 
firm the presence of fibrin, we stained grafts har- 
vested at the time points when fibrin deposition, as 
assessed by TEM, was most dramatic, that is, at 4 
days, 1 week, and 2 weeks. No fibrin was detected in 
the normal epigastric vein. At 4 days fibrin was easily 
distinguished atthe luminal surface. At 1 to 2 weeks 
there was some luminal fibrin (Fig. 8, B). In addi- 
tion, discrete clumps were seen in the media; on the 
basis of size and appearance, these clumps appeared 
to be fibrin-filled empty casts of dead medial SMCs. 
Sections tained with isotype control rabbit IgG were 
negative. 
DISCUSSION 
In this study, we evaluated the ultrastructural 
changes undergone by the components of the vein 
wall after implantation i to an artery. On the basis of 
our previous morphometric and histologic work, 8 we 
examined the proximal region of the vein grafts, 
which experiences the earliest and most dramatic 
Fig. 5. Dense paracrystalline deposits of fibrin 09 with 
mononuclear cells (white arrows) beneath endothelium in 
neointima of 2-week graft. Note IEL (arrowheads) and 
remnants of SMCs (M). Fibroblasts and myofibroblasts 
occupy lower field. L, Lumen; EM ×4300. 
neointimal thickening. The selected time points 
ranged from 1 hour to 12 weeks, when IH is consid- 
ered to be complete. 9 To our knowledge, this is the 
most extensive temporal analysis of ultrastructure in 
a rat model of vein graft IH. 
Studies of vascular remodeling have focused 
largely on the endothelium and the subendothclial 
space. 1°-11 It has been found that both the method of 
vessel preparation and the extent of periadventitial 
tissue disturbance affect reendothelialization7,~2-1s; 
however, even in the gentlest of surgical conditions 
the integrity of the endothelium is compromised. 16 
Whether native or regenerated, the ECs in healing 
vascular tissue most likely are activated. This idea is 
supported by evidence of uttrastructural EC alter- 
ations in grafts with little or no endothelial denuda- 
tion. s,6 In a study by Davies et al. 17 vein graft re- 
sponses to pharmacologic agents were aberrant, even 
after reimplantation into the 'venous circulation; pre- 
sumably, this result was caused by irreversible 
changes in the ECs. It is likely that implantation 
alone causes EC loss, damage, and activation. 5 In our 
model, ECs are incompletely denuded after graft 
implantation, but return by 1 week. IH develops 
despite the early reendothelialization. I  maturing 
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Fig. 6. Myofibroblasts (arrows) present in developing neointima of 4-week graft. Myofibro- 
blasts display extensive rough endoplasmic reficulum and cortical rim of microfilaments. 
Overlying neointima islayer of rounded ECs (arrowheads). L, Lumen; EM × 6000. 
Fig. 7. Myofibroblasts (MF) and more differentiated 
SMCs (arrowhead) in the neointima of a 10-week graft. L, 
Lumen; EM X4300. 
grafts (4 to 12 weeks) the ECs are prominent, with 
more synthetic organdies and cytoplasmic exten- 
sions, which suggests apersistent state of activation. 
None of the regenerated ECs resemble ndothelium 
from normal epigastric vein. Similar findings have 
been demonstrated in human saphenous vein grafts. 6
The source of the regenerating ECs is a matter of 
contention; conflicting reports implicate the adjacent 
artery, valves, and remaining "islands" of ECs as 
potential donors of seeding cells. 13,1s-19 We did not 
attempt to clarify this issue. 
On the basis of  arterial studies, ~,2° venous neoin- 
timal cells are often thought o be SMCs that origi- 
nate in the media. Recent work correlates arterial 
SMC proliferation with neointimal cell prolifera- 
tion21; however, other sources uch as venous adven- 
titial fibroblasts or blood-derived cells have not been 
discounted. In our model, medial SMCs in the con- 
trol vein appear to be clustered quiescent cells. By 1 
hour after surgery degeneration of the medial SMCs 
is seen, and by 1 week no viable SMCs remain within 
the graft. This finding is reproducibly demonstrated 
both by histologic analysis and by ultrastructural 
examination. In addition, in situ DNA end-labeling 
experiments indicate that medial SMCs undergo ap- 
optosis after graft implantation (Hoch, unpublished 
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observation, 1996). Inasmuch as massive medial cell 
death occurs after grafting, it is unlikely that medial 
SMCs are the principal source ofneointimal cellular- 
ity in this model. Evaluation of adjacent arteries was 
not included in our study. 
Interestingly, we have not found SMCs of the 
fully differentiated "contractile" phenotype in the 
healing vein graft. The cells present, seen first in the 
adventitia nd later in the neointima, have irregular 
elongated cell outlines, cytoplasmic extensions, large 
ovoid nuclei, nuclear bodies and nucleoli, microfila- 
ment stress fibers, and abundant rough endoplasmic 
reticulum and Golgi bodies. These characteristics fit 
those of myofibroblasts, which are lmown to persist 
in abnormally healing wounds. 22 The distinction is 
not trivial, as the secretory products of SMCs and 
myofibroblasts are likely to vary and thus have differ- 
ent effects on the microenvironment of the healing 
vein graft. Our findings contrast with other studies 
that reported contractile SMCs in the neointima9,18; 
this discrepancy may reflect differences either be- 
tween the type or age of the veins used for grafting or 
vein graft age. 
Myofibroblastic cells have been described in heal- 
ing vascular tissue. 2s-25 Darby et al. 26 have found in 
experimental wound healing that myofibroblasts de- 
rive from granulation tissue fibroblasts. In the vein 
graft it is conceivable that, in response to stimuli 
within the injured vein, adventitial fibroblasts are 
mobilized to migrate to the neointima nd differen- 
tiate into myofibroblasts. Similar to our findings, Shi 
et al. 24 have demonstrated translocation of adventi- 
tial fibroblasts to the neointima, with phenotypic 
modulation to myofibroblasts, in a porcine coronary 
artery injury model; these cells contained microfila- 
merit stress fibers and well-developed rough endoplas- 
mic reticulum, which are ultrastrucmral characteristics 
of myofibroblasts. 2S Alternatively, the myofibroblasts 
might develop from SMCs, although in our grafts we 
have shown no viable venous SMCs from which they 
might develop. Transdifferentiation of macrophages 
and ECs to myofibroblasts has been recently investi- 
gated. 27-29 
Immunostaining for a-actin has been used al- 
most exclusively to prove the presence of SMCs in 
the neointima of healing veinsa°,al; however, other 
cell types, including myofibroblasts and vascular 
ECs, have been shown to transiently express o~-ac- 
tin. 26-27 Our findings show a decrease in ci-actin- 
positive medial cells after grafting coincident with 
medial SMC death, with reappearance of o~-actin- 
positive cells initially within the adventitia nd later 
in the developing neointima. This pattern of oL-actin 
Fig. 8. Confirmatory immunohistochemical staining of 
vein grafts. A, ED1 + mononuclear phagocytes (arrow- 
heads) within developing neointima (N) of 2-week graft. 
Proximal region, hematoxylin counterstain, x130. Incu- 
bation of serial graft section with mouse IgG 1 revealed no 
staining. B, Indirect immunofluorescence using anti- 
fibrin(ogen) monoclonal antibody of 2-week vein graft 
section shows deposition of fibrin at luminal surface and 
within vessel wall. Staining of serial graft section with 
rabbit IgG was negative. Proximal region, ×80. L, Lumen; 
A, adventitia/media. 
immunostaining of myofibroblasts in healing vein 
grafts is similar to that reported by Shi et al. 24 as 
occurring early after arterial injury. In our model, 
there is a trend toward decreasing neointimal cx-ac- 
tin-positive staining as the vein graft ages. These 
cells, shown by TEM to be myofibroblasts, represent 
a continuum of differentiation and thus variably ex- 
press this protein. Our results agree with Studies that 
showed decreased e~-actin expression i  human vein 
grafts, atherosclerotic plaques, and injured arter- 
ies. ~,32-33 It is clear, nonetheless, that alternate im- 
munophenotypic markers are required to distinguish 
mesenchymal cell types.  27's4 .36 It has been shown in 
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vitro that PDGF expression downregulates ~-actin 
synthesisa7; indeed, the upregulation of PDGF in 
vein grafts 38 may represent a mechanism for the de- 
creased expression of ~-actin. 
Infiltration of healing vein grafts by inflammatory 
cells may also provide a stimulus for subsequent eo- 
intimal development. Neutrophils arrive early at an 
inflammatory site, releasing free radicals and proteo- 
lytic enzymes and often mediating further injury? 9 40 
In our model, the injury caused by manipulation and 
reperfusion of the vein graft may be enhanced by 
neutrophils, which we detect ransmurally after graft- 
ing. Myeloid cells have been identified in animal 7-s,23 
and human s-6,41 vein grafts. In this study, we found 
ultrastructural evidence of persistent mononuclear 
cell emigration. Mononuclear cells rapidly penetrate 
all layers of the vein graft, accumulating in the imme- 
diate subendothelial zone; at later time points they 
appear in a zone of necrosis luminal and abluminal to 
the IEL. The biphasic upregulation of monocyte 
chemotactic protein-1 mRNA in vein grafts as long 
as 12 weeks after vein implantation has been corre- 
lated with macrophage infiltration (Stark et al.42; 
Hoch, unpublished); this protein is a potent and 
specific chemoattractant for these cells. 43 A possible 
role for macrophages in the genesis of IH in vein 
grafts merits further study. 
The venous IEL appears as a discontinuous line 
of amorphous elastin and possibly contributes to the 
relative porosity of the vessel. Disruption of the IEL 
may increase permeability, which indeed has been 
observed in vein grafts. 13 In this study we demon- 
strated attenuation and duplication of the elastica. 
The function ofelastin duplication may be a response 
to the altered hemodynamic environment.* 
In addition to confirming the presence of luminal 
fibrin, we have detected insudation of fibrin into 
empty casts of dead medial SMCs. Even at time 
points after active inflammation has subsided, fibrin 
can be seen in the vein wall. The stimulus for intra- 
cellular fibrin accumulation is unknown. .4 
In this ultrastructural study of rat vein grafts, we 
have examined salient changes that occur in IH de- 
velopment and demonstrated substantial lterations 
in the components of the vein wall. We have found 
that partial endothelial destruction, platelet adhe- 
sion, and polymorphonuclear leukocyte infiltration 
are closely followed by intramural mononuclear cell 
accumulation and fibrin deposition. Medial SMCs 
degenerate and die, leaving empty pseudomyotubes 
bounded by basal lamina and often invested with 
fibrin. Myofibroblastic cells, appearing initially in the 
adventitia, predominate in the maturing neointima. 
A zone of necrosis characterized by cell debris and 
mononuclear cells surrounds the disturbed IEL and 
persists throughout all time points examined. The 
distribution of cells within the vessel wall changes 
with time, increasing in the neointima nd adventitia, 
and diminishing in the media. The mechanisms re- 
sponsible for cellular migration and proliferation that 
lead to neointimal overgrowth remain elusive. This 
study demonstrates that further esearch iswarranted 
to examine the relative roles of mononuclear leuko- 
cytes and myofibroblasts in vein graft healing. 
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